Condition
Stent Implantation
Total Trials
5
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Not Yet Recruiting3
Recruiting1
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07511309Not ApplicableNot Yet Recruiting
FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis
NCT06678074Phase 1Active Not Recruiting
Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI
NCT07116083Recruiting
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
NCT07140133Not Yet Recruiting
Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient
NCT05980195Not ApplicableNot Yet Recruiting
Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial
Showing all 5 trials